Vis enkel innførsel

dc.contributor.authorTehrani, Fahimeh Ramezani
dc.contributor.authorFirouzi, Faezeh
dc.contributor.authorBehboudi-Gandevani, Samira
dc.date.accessioned2021-11-19T12:18:12Z
dc.date.available2021-11-19T12:18:12Z
dc.date.created2021-10-29T08:53:55Z
dc.date.issued2021
dc.identifier.citationTehrani, F. R., Firouzi, F. & Behboudi-Gandevani, S. (2021). Investigating the clinical utility of the anti-mullerian hormone testing for the prediction of age at menopause and assessment of functional ovarian reserve: A practical approach and recent updates. Aging and Disease. doi:en_US
dc.identifier.issn2152-5250
dc.identifier.urihttps://hdl.handle.net/11250/2830492
dc.language.isoengen_US
dc.publisherBuck Institute for Age Researchen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleInvestigating the clinical utility of the Anti-Mullerian Hormone Testing for the prediction of age at menopause and assessment of functional ovarian reserve : A practical approach and Recent Updatesen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2021 The Author(s)en_US
dc.subject.nsiVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750en_US
dc.source.pagenumber10en_US
dc.source.journalAging and Diseaseen_US
dc.identifier.doi10.14336/AD.2021.0825
dc.identifier.cristin1949491


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal